Brooke Story Insider Profile
4 Followers
Brooke Story, Director at LivaNova, holds 7.49K shares in LivaNova (Ticker: LIVN), holds ― shares in PolyPid (Ticker: PYPD), holds ― shares in Sigilon Therapeutics (Ticker: SGTX). Most recently, Brooke Story Sold ― shares of LivaNova on Sep 08, 2026 for an estimated value of $187.27K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-16.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Brooke Story
Brooke Story's Trading History
LivaNova
Sep 08, 2026
Director
Informative Sell
187.27K
$572.31K
PolyPid
―
Director
―
―
Sigilon Therapeutics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Brooke Story's performance on stock
You May Also Like
Brooke Story insider profile FAQ
What is the percentage of profitable transactions made by Brooke Story?
The percentage of profitable transactions made by Brooke Story is 50%.
What is the average return per transaction made by Brooke Story?
The average return per transaction made by Brooke Story is -16.10%.
What stocks does Brooke Story hold?
Brooke Story holds: LIVN, PYPD, SGTX stocks.
What was Brooke Story’s latest transaction?
Brooke Story latest transaction was an Informative Sell of $187.27K.
What was Brooke Story's most profitable transaction?
Brooke Story’s most profitable transaction was an Informative Sell of LIVN stock on September 8, 2026. The return on the trade was 6.90%.
What is Brooke Story's role in LivaNova?
Brooke Story's role in LivaNova is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.